Preimplantation Genetic Screening (PGS)

Preimplantation Genetic Screening (PGS)

Preimplantation genetic screening (PGS) is offered as a complement to a patient’s in vitro fertilisation (IVF) treatment, to
improve pregnancy success rates and reduce miscarriages. Preimplantation genetic screening (PGS) is the testing of early
stage embryos for chromosomal abnormalities. The term “preimplantation” is used because testing is performed on
embryos during the time before they would naturally implant into the uterus. PGS aims to identify chromosomally normal
embryos, prior to transferring embryos to a patient’s uterus. PGS is a comprehensive chromosome screening tool that has
been shown to:

  • Increase IVF pregnancy success rates1
  • Improve implantation outcomes3
  • Decrease miscarriage rates2,3

 

Increase your chances of a healthy pregnancy with the help of PGS.

Preimplantation genetic screening (PGS) is offered as a complement to a patient’s in vitro fertilisation (IVF) treatment, to improve pregnancy success rates and reduce miscarriages.1

Studies have shown that IVF pregnancy rates can be increased with PGS,
when compared to IVF cycles that did not include PGS1.

To learn more about PGS, watch the below video.

1 Yang et al. (2012). Molecular Cytogenetics 5:24
2 Hodes-Wertz et al. (2012). Fertility and Sterility 98:3
3 Yang et al. (2013). Molecular Cytogenetics 6:32

Top